Effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and heart failure

被引：0
|
作者：
Coleman, C. I. [1 ]
Baker, W. L. [1 ]
Bunz, T. J. [2 ]
Eriksson, D. [3 ]
Meinecke, A. K. [3 ]
Sood, N. A. [4 ]
机构：
[1] Univ Connecticut, Pharm Practice, Storrs, CT USA
[2] New England Hlth Analyt LLC, Pharmacoepidemiol, Granby, CO USA
[3] Bayer AG, Berlin, Germany
[4] Southcoast Hlth Syst, Cardiac Electrophysiol, Fall River, MA USA
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4813
引用
收藏
页码：1012 / 1012
页数：1
相关论文
共 50 条
  • [31] Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation
    Aronow, Wilbert S.
    Shamliyan, Tatyana A.
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (06) : E679 - E703
  • [32] A retrospective cohort study of the effectiveness and safety of dabigatran versus rivaroxaban in overweight patients with nonvalvular atrial fibrillation
    Yu, Meixiang
    Wang, Zi
    Zong, Liuliu
    Xu, Qing
    Li, Xiaoye
    Lv, Qianzhou
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (05) : 1149 - 1157
  • [33] A retrospective cohort study of the effectiveness and safety of dabigatran versus rivaroxaban in overweight patients with nonvalvular atrial fibrillation
    Meixiang Yu
    Zi Wang
    Liuliu Zong
    Qing Xu
    Xiaoye Li
    Qianzhou Lv
    International Journal of Clinical Pharmacy, 2022, 44 : 1149 - 1157
  • [34] Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation Insights From ROCKET AF
    van Diepen, Sean
    Hellkamp, Anne S.
    Patel, Manesh R.
    Becker, Richard C.
    Breithardt, Guenter
    Hacke, Werner
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Nessel, Christopher C.
    Singer, Daniel E.
    Berkowitz, Scott D.
    Califf, Robert M.
    Fox, Keith A. A.
    Mahaffey, Kenneth W.
    CIRCULATION-HEART FAILURE, 2013, 6 (04) : 740 - 747
  • [35] Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
    Chan, Yi-Hsin
    See, Lai-Chu
    Tu, Hui-Tzu
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    Wang, Chun-Li
    Kuo, Chang-Fu
    Kuo, Chi-Tai
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [36] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [37] Rivaroxaban versus Warfarin: Effect on Healthcare Resource Utilization and Costs in Nonvalvular Atrial Fibrillation Patients
    Laliberte, Francois
    Crivera, Concetta
    Nelson, Winnie W.
    Olson, William H.
    Schein, Jeffrey
    Germain, Guillaume
    Lefebvre, Patrick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 480 - 481
  • [38] Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoina Hemodialysis
    Coleman, Craig, I
    Kreutz, Reinhold
    Sood, Nitesh A.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Baker, William L.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (09): : 1078 - 1083
  • [39] Effectiveness and safety of rivaroxaban in a cohort of 142 patients with nonvalvular atrial fibrillation treated with rivaroxaban for the prevention of stroke
    Jose Cerezo-Manchado, Juan
    Navarro-Almenzar, Begona
    Elvira Ruiz, Gines
    Garcia-Candel, Faustino
    Flores Blanco, Pedro
    Caro-Martinez, Cesar
    Manzano-Fernandez, Sergio
    Garcia-Iniesta, Natalia
    Sanchez-Garcia, Javier
    Cabanas-Perianes, Valentin
    Moraleda Jimenez, Jose Maria
    FUTURE CARDIOLOGY, 2018, 14 (03) : 31 - 37
  • [40] Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)
    Berger, Jeffrey S.
    Laliberte, Francois
    Kharat, Akshay
    Lejeune, Dominique
    Moore, Kenneth Todd
    Jung, Young
    Lefebvre, Patrick
    Ashton, Veronica
    ADVANCES IN THERAPY, 2021, 38 (07) : 3771 - 3788
12345